Terry-Ann Burrell - Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Terry-Ann Burrell since 12/22/2023

Holdings reported by Terry-Ann Burrell for Recursion Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 71.3K $514K $7.22 Jul 1, 2024 Direct
Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct Class A Common Stock

Transactions reported by Terry-Ann Burrell for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.